Dr. Charles Billington, MD

• Endocrinology, Diabetes & Metabolism

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Kansas School Of Medicine

  Medical School, 1981

• Sleep disorders, obesity, and aging: the role of orexin, 2014-11-22

• Neuromodulation of Orexin Neurons Reduces Diet-Induced Adiposity, 2017-11-28

• Serum FABP4 Concentrations Decrease Following Roux-en-Y Gastric Bypass But Not After Intensive Medical Management, 2018-10-01

• Neuropeptides controlling energy balance: orexins and neuromedins, 2016-01-28

• Results From a Trial of an Online Diabetes Prevention Program Intervention, 2018-09-24

• Genomic and biochemical analysis of repeatedly observed variants in DBT in individuals with maple syrup urine disease of Central American ancestry, 2022-07-07

• Sleep and Obesity: A focus on animal models, 2012-01-16

• Orexin: Pathways to obesity resistance?, 2016-01-28

• Meal-Replacements followed by Topiramate for the Treatment of Adolescent Severe Obesity: A Pilot Randomized Controlled Trial, 2016-11-03

• Elevated Sleep Quality and Orexin Receptor mRNA in Obesity Resistant Rats, 2010-05-25

• Effect of Housing Types on Growth, Feeding, Physical Activity, and Anxiety-Like Behavior in Male Sprague-Dawley Rats, 2016-02-04

• Exercise reduces diet-induced cognitive decline and increases hippocampal brain-derived neurotrophic factor in CA3 neurons, 2014-04-19

• Spontaneous Physical Activity Defends Against Obesity, 2017-11-06

• Copper-Binding Domain Variation in a Novel Murine Lysyl Oxidase Model Produces Structurally Inferior Aortic Elastic Fibers Whose Failure Is Modified by Age, Sex, and Blood Pressure, 2022-06-17

• Impact of retinoic acid exposure on midfacial shape variation and manifestation of holoprosencephaly inTwsg1mutant mice, 2014-12-02

• Role of orexin A signaling in dietary palmitic acid-activated microglial cells, 2015-08-22

• Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia, 2008-12-24

• Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial, 2016-08-10

• Orexin/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice, 2017-10-28

• Implementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial, 2015-05-12

• Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial, 2015-07-12

• Use of a bio-electronic device comprising of targeted dual neuromodulation of the hepatic and celiac vagal branches demonstrated enhanced glycemic control in a type 2 diabetic rat model as well as in an Alloxan treated swine model, 2022-10-25

• Partial sleep deprivation by environmental noise increases food intake and body weight in obesity resistant rats, 2013-05-13

• Role of spontaneous physical activity in prediction of susceptibility to activity based anorexia in male and female rats, 2014-06-07

• The molecular and cellular basis of variable craniofacial phenotypes and their genetic rescue inTwisted gastrulationmutant mice, 2011-04-28

• Exenatide as a Weight-Loss Therapy in Extreme Pediatric Obesity A Randomized, Controlled Pilot Study, 2011-11-10

• Twisted gastrulation limits apoptosis in the distal region of the mandibular arch in mice, 2009-01-20

• National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m2), 2016-10-25

• WNT5AMutations in Patients with Autosomal Dominant Robinow Syndrome, 2014-05-07

• Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study, 2016-04-05